Drug Profile
Anti-MHC monoclonal antibodies
Alternative Names: Anti-MHC; Anti-MHC class I monoclonal antibody; Anti-MHC class II monoclonal antibody; Anti-MHC monoclonal antibodyLatest Information Update: 25 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source; Yamaguchi University
- Developer Nonindustrial source
- Class Antihyperglycaemics; Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Graft-versus-host disease; Transplant rejection